Skip to content
10-Q

Quarterly Report

Codiak BioSciences, Inc.

0000950170-22-014755

← back to feed
Filed
Aug 4, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Jul 29, 2022 22.66M sh
Capex Q2 2022 · Jun 30, 2022 $353K
Capex Q2 2022 · Jun 30, 2021 $2.37M
Operating Cash Flow Q2 2022 · Jun 30, 2022 −$35.45M
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$37.32M
Cash And Equivalents Q2 2022 · Jun 30, 2022 $41.79M
Cash And Equivalents Q2 2022 · Dec 31, 2021 $76.94M
Cash And Equivalents Q2 2022 · Jun 30, 2021 $113.68M
Stockholders Equity Q2 2022 · Jun 30, 2022 $44.4M
Stockholders Equity Q2 2022 · Mar 31, 2022 $48.38M
Stockholders Equity Q2 2022 · Dec 31, 2021 $53.51M
Stockholders Equity Q2 2022 · Jun 30, 2021 $51.86M
Stockholders Equity Q2 2022 · Mar 31, 2021 $68.72M
Stockholders Equity Q2 2022 · Dec 31, 2020 $14.57M
Current Liabilities Q2 2022 · Jun 30, 2022 $12.01M
Current Liabilities Q2 2022 · Dec 31, 2021 $27.17M
Total Liabilities Q2 2022 · Jun 30, 2022 $88.31M
Total Liabilities Q2 2022 · Dec 31, 2021 $118.17M
Current Assets Q2 2022 · Jun 30, 2022 $56.01M
Current Assets Q2 2022 · Dec 31, 2021 $90.17M
Total Assets Q2 2022 · Jun 30, 2022 $132.71M
Total Assets Q2 2022 · Dec 31, 2021 $171.67M
Sga Expense Q2 2022 · Jun 30, 2022 $7.36M
Sga Expense Q2 2022 · Jun 30, 2022 $14.07M
Sga Expense Q2 2022 · Jun 30, 2021 $6.94M
Sga Expense Q2 2022 · Jun 30, 2021 $13.53M
Rd Expense Q2 2022 · Jun 30, 2022 $12.8M
Rd Expense Q2 2022 · Jun 30, 2022 $27.05M
Rd Expense Q2 2022 · Jun 30, 2021 $15.42M
Rd Expense Q2 2022 · Jun 30, 2021 $31.97M
Net Income Q2 2022 · Jun 30, 2022 −$6.78M
Net Income Q2 2022 · Jun 30, 2022 −$14.8M
Net Income Q2 2022 · Mar 31, 2022 −$8.03M
Net Income Q2 2022 · Jun 30, 2021 −$21.81M
Net Income Q2 2022 · Jun 30, 2021 −$32.12M
Net Income Q2 2022 · Mar 31, 2021 −$10.31M
Operating Income Q2 2022 · Jun 30, 2022 −$7.02M
Operating Income Q2 2022 · Jun 30, 2022 −$15.27M
Operating Income Q2 2022 · Jun 30, 2021 −$21.47M
Operating Income Q2 2022 · Jun 30, 2021 −$31.41M
Revenue Q2 2022 · Jun 30, 2022 $13.15M
Revenue Q2 2022 · Jun 30, 2022 $25.85M
Revenue Q2 2022 · Jun 30, 2021 $890K
Revenue Q2 2022 · Jun 30, 2021 $14.08M
Stock Issued Q2 2022 · Feb 17, 2021 3.16M sh
Stock Issued Q2 2022 · Oct 16, 2020 5.5M sh